ArticleHemaSphere2026

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases.

Alexander Carpinteiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.